Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil

Solid lipid nanoparticles (SLNs) have the potential to enhance the systemic availability of an active pharmaceutical ingredient (API) or reduce its toxicity through uptake of the SLNs from the gastrointestinal tract or controlled release of the API, respectively. In both aspects, the responses of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Amekyeh, Hilda, Billa, Nashiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914714/
https://www.ncbi.nlm.nih.gov/pubmed/33572168
http://dx.doi.org/10.3390/molecules26040908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914714/
https://www.ncbi.nlm.nih.gov/pubmed/33572168
http://dx.doi.org/10.3390/molecules26040908

Ejemplares similares